Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Iterative Health has developed SKOUT, an FDA-cleared real-time AI tool that assists physicians during colonoscopies by detecting polyps to improve colorectal cancer screening. The company also provides AI-driven solutions to automate IBD scoring and optimize patient recruitment for GI clinical trials. Their technology is deployed across a growing network of GI research sites in the US and Europe, with partnerships involving major pharmaceutical companies such as Eli Lilly and Johnson & Johnson. No direct therapeutic or drug efficacy results are reported as the focus is on diagnostics and trial enablement.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Iterative Health.